Plasma Care

PlasmaCare is a prominent American healthcare company specializing in the collection of human source plasma, which is the essential raw material for manufacturing plasma-derived therapies. Founded in 1985 and headquartered in Cincinnati, Ohio, the company was acquired by the global biopharmaceutical leader Grifols in 2006 for approximately $280 million. PlasmaCare operates an extensive network of FDA-licensed donor centers across the United States, ensuring a stable and high-quality supply of plasma for its parent company's therapeutic portfolio. These plasma-derived products are critical for treating patients with rare, chronic, and life-threatening conditions such as primary immunodeficiencies, hemophilia, and genetic emphysema. As a key subsidiary of Grifols, PlasmaCare plays a vital role in the global supply chain for protein-based medicines and maintains rigorous safety and quality standards throughout the collection process.